In bladder cancer, malignant melanoma, and prostate cancer, N-cadherin promotes tumor cell invasion by activating signaling pathways and inhibits tumor cell apoptosis, which is conducive to tumor cell survival (37, 38). Here, CDH2 is linked to prostate carcinoma.